Scientists are testing a procedure that allows women with a genetic disorder conceive without passing the disease on to their children, and it involves using DNA from a "third parent." Is it ethical?
UK scientists have discovered a procedure that will help women with a rare genetic disorder conceive without passing the disease on to their children. The procedure-dubbed “three-parent IVF” in the press-involves swapping out a small set of faulty mitochondrial genes and replacing them with the genes of another woman. Scientists estimate that only 0.1% of the child’s DNA will originate from the third party, and it would not make the third party a legal or biological parent.
Faulty mitochondrial genes can cause a range of debilitating or fatal problems with the heart, liver, and kidneys. The Nuffield Council on Bioethics concluded that mitochondrial donation is ethical, and scientists hope to begin animal studies soon. Do you agree with the decision to allow mitochondrial donation for “three-parent IVF”?
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Listen
Similar live birth rates found for blastocyst vs cleavage stage embryo transfers in IVF treatment
September 24th 2024A recent study found no significant difference in live birth rates between blastocyst and cleavage stage embryo transfers in women with 4 or more embryos during in vitro fertilization.
Read More